Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Charles K. Gayer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alane P. Barnes - $3.46M of BCRX open-market activity in the last 12 months
- Theresa Heggie - $505K of BCRX open-market activity in the last 12 months
- Amy E. McKee - $100K of BCRX open-market activity in the last 12 months
- Machelle Sanders - $69K of BCRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Charles K. Gayer?
Charles K. Gayer is a corporate insider, tracked as President and CCO of BIOCRYST PHARMACEUTICALS INC (BCRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Charles K. Gayer last file a Form 4?
The most recent primary Form 4 on record is dated 23 December 2025, one of 5 filings going back to 2024.
Where can I see all of Charles K. Gayer's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Charles K. Gayer and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
